$INDP 3 SEC Filings

Filed On	Filing
20 Apr 2026	Form 3: Lu Qinglai, Director No securities owned
02 Apr 2026	Form 3: Yao Yun, 10% owner Holds 41,991,000 shares of Common Stock
02 Apr 2026	Form 3: Sino Lion Ventures Ltd, 10% owner Holds 38,895,000 shares of Common Stock
02 Apr 2026	Form 3: Dai Junyi, Chief Executive Officer Holds 11,250,000 shares of Common Stock
27 Feb 2026	Form 3: Jabbour Jerome D, Director No securities owned
26 Feb 2026	Form 3: McMurdo Matthew Charles, Director Holds 25,000 shares of Common Stock
12 Jan 2026	Form 3: Natan David, Director Holds 0 shares of No securities are beneficially owned.
23 Dec 2025	Form 3: Lazar David E., Co-Chief Executive Officer Holds 0 shares of Common Stock
23 Dec 2025	Form 3: Ben-Tzvi Avraham, Director Holds 100 shares of Common Stock
07 Aug 2023	Form 3: Waltzman Roger J., Chief Medical Officer No securities owned
14 Feb 2023	Form 3: Martell Robert, Director No securities owned
07 Jul 2022	Form 3: Anderson Glen R., 10% owner Holds 113,918 shares of Common Stock
02 Feb 2022	Form 3: Litchev Boyan Vesselinov, Chief Medical Officer No securities owned
08 Dec 2021	Form 3: Gilbert Mark John, Director No securities owned
06 Aug 2021	Form 3: Lee Hoonmo, Director Holds 694,522 shares of Common Stock
06 Aug 2021	Form 3: Newman Michael James, Director Holds 1,388,356 shares of Common Stock
06 Aug 2021	Form 3: O'callaghan Brian, Director
02 Aug 2021	Form 3: Hayes William B, Director
02 Aug 2021	Form 3: Karah Hila, Director
02 Aug 2021	Form 3: Linscott Walt Addison, Chief Business Officer

Comments